Decoding Bone Marrow Architecture: A New Biomarker for Disease Activity and Treatment Response in Myelodysplastic Neoplasms
Spatial remodeling of bone marrow in myelodysplastic neoplasms (MDS) reveals distinctive tissue-state signatures that better capture disease activity and predict therapeutic response beyond traditional blast counts.
